Martin Jädersten

6.0k total citations
63 papers, 2.1k citations indexed

About

Martin Jädersten is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Martin Jädersten has authored 63 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hematology, 23 papers in Genetics and 19 papers in Molecular Biology. Recurrent topics in Martin Jädersten's work include Acute Myeloid Leukemia Research (44 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Multiple Myeloma Research and Treatments (9 papers). Martin Jädersten is often cited by papers focused on Acute Myeloid Leukemia Research (44 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Multiple Myeloma Research and Treatments (9 papers). Martin Jädersten collaborates with scholars based in Sweden, United Kingdom and Germany. Martin Jädersten's co-authors include Eva Hellström‐Lindberg, Eva Hellström‐Lindberg, Andrea Pellagatti, Luca Malcovati, Jacqueline Boultwood, Matteo Giovanni Della Porta, Mario Cazzola, Anna Porwit, James S. Wainscoat and Ingunn Dybedal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Martin Jädersten

59 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Jädersten Sweden 22 1.7k 857 795 263 241 63 2.1k
Olivier Kosmider France 26 1.6k 0.9× 1.2k 1.4× 1.0k 1.3× 220 0.8× 227 0.9× 107 2.5k
Brenton G. Mar United States 16 1.5k 0.9× 982 1.1× 667 0.8× 260 1.0× 302 1.3× 33 2.3k
Andrea Kündgen Germany 19 2.1k 1.3× 655 0.8× 1.1k 1.3× 231 0.9× 171 0.7× 50 2.4k
Eva Hellström‐Lindberg Sweden 20 1.5k 0.9× 855 1.0× 758 1.0× 152 0.6× 167 0.7× 29 1.9k
Erica Travaglino Italy 20 2.0k 1.2× 488 0.6× 1.3k 1.6× 253 1.0× 145 0.6× 57 2.3k
Carlos Bueso-Ramos United States 18 1.0k 0.6× 750 0.9× 572 0.7× 208 0.8× 203 0.8× 37 1.7k
Andrew Duncombe United Kingdom 18 1.1k 0.7× 1.2k 1.4× 915 1.2× 145 0.6× 174 0.7× 35 2.0k
Stephen E. Langabeer Ireland 20 2.3k 1.3× 1.3k 1.5× 959 1.2× 251 1.0× 213 0.9× 104 2.7k
Lydia Roy France 22 1.4k 0.8× 551 0.6× 1.1k 1.4× 329 1.3× 259 1.1× 65 2.1k
Janice M. Hodnefield United States 18 1.3k 0.8× 727 0.8× 763 1.0× 379 1.4× 150 0.6× 28 1.7k

Countries citing papers authored by Martin Jädersten

Since Specialization
Citations

This map shows the geographic impact of Martin Jädersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Jädersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Jädersten more than expected).

Fields of papers citing papers by Martin Jädersten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Jädersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Jädersten. The network helps show where Martin Jädersten may publish in the future.

Co-authorship network of co-authors of Martin Jädersten

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Jädersten. A scholar is included among the top collaborators of Martin Jädersten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Jädersten. Martin Jädersten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Garelius, Hege, Lars Nilsson, Caroline E. Weibull, et al.. (2023). Therapy-related MDS dissected based on primary disease and treatment—a nationwide perspective. Leukemia. 37(5). 1103–1112. 7 indexed citations
4.
Mortera‐Blanco, Teresa, Pedro Luís Moura, Gunilla Walldin, et al.. (2022). The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS. Blood Advances. 6(16). 4705–4709. 2 indexed citations
5.
Greenwood, Tatiana von Bahr, Martin Jädersten, Egle Kvedaraite, et al.. (2022). Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma. British Journal of Haematology. 198(4). 721–728. 11 indexed citations
6.
Eriksson, Anna, Martin Jädersten, Vladimir Lazarević, et al.. (2022). A risk score based on real-world data to predict early death in acute promyelocytic leukemia. Haematologica. 107(7). 1528–1537. 12 indexed citations
7.
Martínez-Høyer, Sergio, Yu Deng, Jeremy Parker, et al.. (2020). Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome. Nature Cell Biology. 22(5). 526–533. 31 indexed citations
8.
Kvedaraite, Egle, Magda Lourda, Hongya Han, et al.. (2020). Patients with both Langerhans cell histiocytosis and Crohn’s disease highlight a common role of interleukin‐23. Acta Paediatrica. 110(4). 1315–1321. 4 indexed citations
9.
Carlsten, Mattias, Martin Jädersten, Karin Littmann, et al.. (2019). The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016. Experimental Hematology and Oncology. 8(1). 7–7. 11 indexed citations
10.
Folkvaljon, Yasin, J. Sundberg, Mats Lambe, et al.. (2016). VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR MYELODYSPLASTIC SYNDROMES IN THE SWEDISH MDS-REGISTER. Haematologica. 101. 243–243. 1 indexed citations
11.
Ljungström, Viktor, Jakob Werner Hansen, Astrid Olsnes Kittang, et al.. (2016). Molecular Profiling In A Population Based Cohort Of Nordic Myelodysplastic Syndrome Patients. Haematologica. 101. 72–72. 1 indexed citations
12.
Jädersten, Martin, Leonie Saft, Alexander Smith, et al.. (2011). TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression. Journal of Clinical Oncology. 29(15). 1971–1979. 332 indexed citations
13.
Pellagatti, Andrea, Mario Cazzola, Aristoteles Giagounidis, et al.. (2010). Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia. 24(4). 756–764. 188 indexed citations
14.
Carlsten, Mattias, Bettina C. Baumann, Martin Jädersten, et al.. (2010). Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome. Leukemia. 24(9). 1607–1616. 87 indexed citations
15.
Pellagatti, Andrea, Teresa Marafioti, Jennifer C. Paterson, et al.. (2009). Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. British Journal of Haematology. 146(1). 86–90. 18 indexed citations
16.
Boultwood, Jacqueline, Andrea Pellagatti, Maryam Nikpour, et al.. (2008). The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts. PLoS ONE. 3(4). e1970–e1970. 87 indexed citations
17.
Pellagatti, Andrea, Martin Jädersten, Ann‐Mari Forsblom, et al.. (2007). Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q− syndrome patients. Proceedings of the National Academy of Sciences. 104(27). 11406–11411. 170 indexed citations
18.
Jädersten, Martin, Scott Montgomery, Ingunn Dybedal, Anna Porwit‐MacDonald, & Eva Hellström-Lindberg. (2005). Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood. 106(3). 803–811. 143 indexed citations
19.
Jädersten, Martin, Andrea Pellagatti, Ann‐Mari Forsblom, et al.. (2005). Lenalidomide Selectively Inhibits In Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion.. Blood. 106(11). 3438–3438. 2 indexed citations
20.
Jädersten, Martin, et al.. (1994). Biphasic effect of transforming growth factor-beta on Epstein-Barr virus-induced activation of human tonsillar B cells. Immunology Letters. 40(2). 111–115. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Kosmider Breakdown of academic impact, for papers by Brenton G. Mar Breakdown of academic impact, for papers by Andrea Kündgen Breakdown of academic impact, for papers by Eva Hellström‐Lindberg Breakdown of academic impact, for papers by Erica Travaglino Breakdown of academic impact, for papers by Carlos Bueso-Ramos Breakdown of academic impact, for papers by Andrew Duncombe Breakdown of academic impact, for papers by Stephen E. Langabeer Breakdown of academic impact, for papers by Lydia Roy Breakdown of academic impact, for papers by Janice M. Hodnefield
Rankless by CCL
2026